$29-$31 target, page-5

First 5 Last

Share
Profile

Follow
oldnrooted

755 Posts.

14

31/01/20

17:51

Post #: 42680152
Share

Originally posted by JustSayin: ↑

The Appen Ltd(ASX: APX) share price has been on fire so far in 2020.
Since the start of the year the machine learning and artificial intelligence company’s shares have rallied 15% higher.
This means they have now climbed a sizeable 61% over the last 12 months.
Why is the Appen share price racing higher?
Investors have been scrambling to buy Appen’s shares due to its strong performance in FY 2019.
Next month the global leader in the development of high-quality, human annotated datasets for machine learning and artificial intelligence will release its full year results and is widely expected to outperform its guidance.
Due to stronger than expected demand for its Content Relevance services during the second half, in November Appen lifted its guidance materially.
It was expecting underlying EBITDA to be between $85 million and $90 million in FY 2019, which represented a 19% to 26.2% increase on FY 2018’s result.
But the strong demand led to management lifting its underlying EBITDA guidance to be in the range of $96 million to $99 million. This implies year on year growth of 34.6% to 38.8%.
Management also advised that its guidance was subject to currency movements. It suggested that a further $1 million to $1.5 million could be added to its underlying EBITDA if the Australian dollar didn’t strengthen.
Despite a brief strengthening in December, this has proven to be the case. In fact, the Australian dollar is currently trading a touch lower than where it stood at the time of its update in mid-November.
Should you invest?
With the machine learning and artificial intelligence market tipped to grow materially over the next decade, I believe Appen is well-positioned to continue growing its earnings at a rapid rate for many years to come.
In light of this, I continue to believe Appen could be a great long-term investment option along with fellow tech stars Altium Limited(ASX: ALU) and Xero Limited(ASX: XRO).
As well as Appen, I think these highly rated growth shares would be great options for investors in February.

Expand

is this your report Justsayin?
Cheers,

APX Price at posting: $25.35 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

There are more pages in this discussion • 259 more messages in this thread...

First 5 Last

Add APX (ASX) to my watchlist

(20min delay)
Last 62.0¢		Change 0.010(1.64%)		Mkt cap ! $138.9M

Open	High	Low	Value	Volume
62.5¢	63.5¢	61.5¢	$739.4K	1.181M

Buyers (Bids)

No.	Vol.	Price($)
11	152214	61.5¢

Sellers (Offers)

Price($)	Vol.	No.
62.5¢	114220	17

View Market Depth

No.	Vol.	Price($)
6	45071	0.620
10	134082	0.615
19	269380	0.610
6	148638	0.605
22	538393	0.600

Price($)	Vol.	No.
0.625	96884	17
0.630	167043	15
0.635	189806	17
0.640	140080	15
0.645	312672	7

Last trade - 15.02pm 15/05/2024 (20 minute delay)


Last 62.0¢		Change 0.010 ( 1.27 %)
Open	High	Low	Volume
61.0¢	63.0¢	61.0¢	292500
Last updated 15.14pm 15/05/2024 ?

APX (ASX) Chart

$29-$31 target, page-5

Featured News

Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management

Want copper with that? Boss Energy hits orange metal on-site uranium play

Market Update: Materials and health push ASX up

Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing

Recce Pharma heading closer to full efficacy data for flagship R327

Buyers (Bids)

Sellers (Offers)

Featured News

$29-$31 target, page-5

Featured News

Top Stories

Retail Revolution: Shekel Brainweigh leads the charge in Digital Inventory Management

Want copper with that? Boss Energy hits orange metal on-site uranium play

Market Update: Materials and health push ASX up

Is IPO mania back for the ASX? Sun Silver jumps 100% on first day of listing

Recce Pharma heading closer to full efficacy data for flagship R327

Buyers (Bids)

Sellers (Offers)

Featured News